|
|
|
|
Known Diseases associated with this Protein: | APOE KYOTO
| APOE SENDAI
| APOE-SUITA
| APOE2 VARIANT
| APOE2-DUNEDIN
| APOE2-FUKUOKA
| APOE3 VARIANT
| APOE3(-)-FREIBURG
| APOE3(-)-KOCHI
| APOE3-WASHINGTON
| APOE4 VARIANT
| APOE4(+)
| APOE4(-)-FREIBURG
| APOLIPOPROTEINEMIA E1
| DYSBETALIPOPROTEINEMIA DUE TO APOE2
| FAMILIAL DYSBETALIPOPROTEINEMIA
| HYPERCHOLESTEROLEMIA AND HYPERTRIGLYCERIDEMIA, TYPE III
| HYPERLIPOPROTEINEMIA 3 (HLPP3)
| HYPERLIPOPROTEINEMIA, TYPE III
| HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE DEFICIENCY
| HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE2
| HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE2-FUKUOKA
| HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE4
| HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE7
| HYPERLIPOPROTEINEMIA, TYPE III, AUTOSOMAL DOMINANT
| HYPERLIPOPROTEINEMIA, TYPE III, DUE TO APOE1-HARRISBURG
| HYPERLIPOPROTEINEMIA, TYPE III, DUE TO APOE2-CHRISTCHURCH
| HYPERLIPOPROTEINEMIA, TYPE III, DUE TO APOE4-PHILADELPHIA
| LIPOPROTEIN GLOMERULOPATHY
| LIPOPROTEIN GLOMERULOPATHY (LPG)
|
| | Tips: The Domains on the Default View are decided by the Domain's E-Value. Clicking a check box will display or hide the correlated domain. To view the Gene page, either click on the link to the left or the blue bar above the Protein's graphic. |
---|
Default View:
| |
---|
Domains found on the Protein Domain ↕ | CD Accession ↕ | E-Value ↕ | Start ↕ | End ↕ |
---|
Table of Mutations found on the ProteinSource ↕ | Mut_ID ↕ | Class ↕ | HGVS ↕ | Disease ↕ |
---|
Swiss-Prot | VAR_000663 | Polymorphism | p.ALA170PRO | N/A | Swiss-Prot | VAR_000651 | Polymorphism | p.ALA117THR | N/A | Swiss-Prot | VAR_016789 | Polymorphism | p.ALA124VAL | N/A | Swiss-Prot | VAR_000657 | Disease | p.ARG154CYS | Hyperlipoproteinemia 3 (HLPP3) | Swiss-Prot | VAR_000658 | Disease | p.ARG160CYS | Hyperlipoproteinemia 3 (HLPP3) | Swiss-Prot | VAR_000659 | Disease | p.ARG163CYS | Hyperlipoproteinemia 3 (HLPP3) | dbSNP | rs7412 | Disease | p.ARG176CYS | Hyperlipoproteinemia 3 (HLPP3) | Swiss-Prot | VAR_000666 | Polymorphism | p.ARG246CYS | N/A | Swiss-Prot | VAR_042734 | Disease | p.ARG43CYS | Lipoprotein glomerulopathy (LPG) | Swiss-Prot | VAR_000655 | Polymorphism | p.ARG152GLN | N/A | Swiss-Prot | VAR_000665 | Polymorphism | p.ARG242GLN | N/A | Swiss-Prot | VAR_000669 | Polymorphism | p.ARG269GLY | N/A | Swiss-Prot | VAR_000660 | Polymorphism | p.ARG163HIS | N/A | Swiss-Prot | VAR_000671 | Polymorphism | p.ARG292HIS | N/A | Swiss-Prot | VAR_042735 | Disease | p.ARG163PRO | Lipoprotein glomerulopathy (LPG) | Swiss-Prot | VAR_000656 | Disease | p.ARG154SER | Hyperlipoproteinemia 3 (HLPP3) | dbSNP | rs429358 | Disease | p.CYS130ARG | Hyperlipoproteinemia 3 (HLPP3) | Swiss-Prot | VAR_014114 | Polymorphism | p.GLN64HIS | N/A | Swiss-Prot | VAR_000649 | Polymorphism | p.GLN99LYS | N/A | Swiss-Prot | VAR_000645 | Polymorphism | p.GLU21LYS | N/A | Swiss-Prot | VAR_000646 | Disease | p.GLU31LYS | Hyperlipoproteinemia 3 (HLPP3) | Swiss-Prot | VAR_000653 | Polymorphism | p.GLY145ASP | N/A | Swiss-Prot | VAR_000670 | Polymorphism | p.LEU270GLU | N/A | Swiss-Prot | VAR_000647 | Polymorphism | p.LEU46PRO | N/A | Swiss-Prot | VAR_000661 | Disease | p.LYS164GLN | Hyperlipoproteinemia 3 (HLPP3) | Swiss-Prot | VAR_000662 | Disease | p.LYS164GLU | Hyperlipoproteinemia 3 (HLPP3) | Swiss-Prot | VAR_000650 | Polymorphism | p.PRO102ARG | N/A | Swiss-Prot | VAR_000672 | Polymorphism | p.SER314ARG | N/A | Swiss-Prot | VAR_000648 | Polymorphism | p.THR60ALA | N/A | Swiss-Prot | VAR_000667 | Polymorphism | p.VAL254GLU | N/A | OMIM | 107741.0026 | Disease | p.ALA152PRO | APOE3 VARIANT | OMIM | 107741.0026 | Disease | p.ALA99THR | APOE3 VARIANT | OMIM | 107741.0008 | Disease | p.ARG142CYS | HYPERLIPOPROTEINEMIA, TYPE III, AUTOSOMAL DOMINANT||FAMILIAL DYSBETALIPOPROTEINEMIA | OMIM | 107741.0004 107741.0013 | Disease | p.ARG145CYS | HYPERLIPOPROTEINEMIA, TYPE III, DUE TO APOE4-PHILADELPHIA | OMIM | 107741.0009 | Disease | p.ARG148CYS | APOLIPOPROTEINEMIA E1 | OMIM | 107741.0001 107741.0019 107741.0021 | Disease | p.ARG158CYS | HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE2 | OMIM | 107741.0012 | Disease | p.ARG228CYS | APOE2-DUNEDIN | OMIM | 107741.0033 | Disease | p.ARG25CYS | LIPOPROTEIN GLOMERULOPATHY||APOE KYOTO | OMIM | 107741.0027 | Disease | p.ARG134GLN | APOE2 VARIANT | OMIM | 107741.0019 | Disease | p.ARG224GLN | HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE2-FUKUOKA||APOE2-FUKUOKA | OMIM | 107741.0022 | Disease | p.ARG251GLY | HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE4 | OMIM | 107741.0018 | Disease | p.ARG145HIS | HYPERLIPOPROTEINEMIA, TYPE III||APOE3(-)-KOCHI | OMIM | 107741.0028 | Disease | p.ARG274HIS | APOE4 VARIANT | OMIM | 107741.0032 | Disease | p.ARG145PRO | LIPOPROTEIN GLOMERULOPATHY||APOE SENDAI | OMIM | 107741.0003 | Disease | p.ARG136SER | HYPERLIPOPROTEINEMIA, TYPE III, DUE TO APOE2-CHRISTCHURCH | OMIM | 107741.0008 107741.0016 107741.0022 107741.0023 107741.0025 | Disease | p.CYS112ARG | APOE4 VARIANT | OMIM | 107741.0013 107741.0020 | Disease | p.GLU13LYS | HYPERCHOLESTEROLEMIA AND HYPERTRIGLYCERIDEMIA, TYPE III | OMIM | 107741.0007 | Disease | p.GLU244LYS | HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE7||APOE-SUITA | OMIM | 107741.0007 | Disease | p.GLU245LYS | HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE7||APOE-SUITA | OMIM | 107741.0002 107741.0020 | Disease | p.GLU3LYS | HYPERCHOLESTEROLEMIA AND HYPERTRIGLYCERIDEMIA, TYPE III | OMIM | 107741.0009 | Disease | p.GLY127ASP | APOLIPOPROTEINEMIA E1 | OMIM | 107741.0023 | Disease | p.LEU28PRO | APOE4(-)-FREIBURG | OMIM | 107741.0011 | Disease | p.LYS146GLN | DYSBETALIPOPROTEINEMIA DUE TO APOE2 | OMIM | 107741.0010 | Disease | p.LYS146GLU | HYPERLIPOPROTEINEMIA, TYPE III, DUE TO APOE1-HARRISBURG | OMIM | 107741.0025 | Disease | p.PRO84ARG | APOE4 VARIANT | OMIM | 107741.0029 | Disease | p.SER296ARG | APOE4(+) | OMIM | 107741.0024 | Disease | p.THR42ALA | APOE3(-)-FREIBURG | OMIM | 107741.0014 | Disease | p.TRP210TER | HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE DEFICIENCY||APOE3-WASHINGTON | OMIM | 107741.0021 | Disease | p.VAL236GLU | HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE2 |
Please Cite: Peterson, T.A., Adadey, A., Santana-Cruz ,I., Sun, Y., Winder A, Kann, M.G., (2010) DMDM: Domain Mapping of Disease Mutations. Bioinformatics 26 (19), 2458-2459.
DMDM_info@umbc.edu | 1000 Hilltop Circle, Baltimore, MD
21250 | Department of Biological Sciences | Phone: 410-455-2258 |
|